Clinical Trial

Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation

Study acronym: CRT-SCHZ
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2025 (before its estimated August 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to determine whether Cognitive Remediation Therapy (CRT) can improve attention, memory, and emotional regulation in people with schizophrenia. CRT is a structured program that includes exercises to strengthen cognitive skills such as problem-solving, working memory, and emotion regulation. The study will recruit 60 participants: 30 individuals with schizophrenia and 30 healthy individuals of similar age and gender. Those with schizophrenia will be randomly assigned to either receive CRT or be placed on a waitlist without therapy. All participants will undergo non-invasive brain activity (EEG) and emotional response (GSR) recordings before and after the therapy. The study's main question is: Does participating in a 12-week CRT program improve brain-based markers of attention and emotional regulation in people with schizophrenia? Additional tests, such as memory and emotion recognition tasks and self-report questionnaires, will help assess changes in thinking skills and emotional well-being. The study may help better understand how CRT affects both brain function and quality of life in schizophrenia.
Trial Details
NCT Number NCT06936397
Lead Sponsor Beykoz University
Collaborators: Uskudar University, Istanbul Nisantasi University
Conditions Schizophrenia Disorders, Cognitive Dysfunction, Emotion Regulation Disorders
Enrollment 60 participants
Start Date 2025-03-15
Primary Completion 2025-08-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-20